SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Zhen-Xin Zhang, Honglei Chen, Sheng-Di Chen, Ming Shao, Sheng-Gang Sun, Qiu-Min Qu, Bao-Rong Zhang, Yi-Ming Liu, Qun Xu, Xia Wan, Ling Li, Hong-Bo Wen, Xia Chen, Hai-Bo Chen, Zhen-Guo Liu, Jian Wang, Gang Wang, Chinese culture permeation in the treatment of Parkinson disease: a cross-sectional study in four regions of China, BMC Research Notes, 2014, 7, 1, 65

    CrossRef

  2. 2
    Wafa Regragui, Lamiae Lachhab, Rachid Razine, Leila Raissouni, Khaoula Rasmouni, Fatima Imounan, El hachmia Benhaddou, Redouane Abouqal, Ali Benomar, Mohamed Yahyaoui, Profile of idiopathic parkinson’s disease in Moroccan patients, International Archives of Medicine, 2014, 7, 1, 10

    CrossRef

  3. 3
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, Á. Sesar, F. Valldeoriola-Serra, R. Yañez, Advanced Parkinson's disease: Clinical characteristics and treatment. Part II, Neurología (English Edition), 2013, 28, 9, 558

    CrossRef

  4. 4
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, Á. Sesar, F. Valldeoriola-Serra, R. Yañez, Enfermedad de Parkinson avanzada. Características clínicas y tratamiento. Parte II, Neurología, 2013, 28, 9, 558

    CrossRef

  5. 5
    Elke Heremans, Alice Nieuwboer, Sarah Vercruysse, Freezing of Gait in Parkinson’s Disease: Where Are We Now?, Current Neurology and Neuroscience Reports, 2013, 13, 6

    CrossRef

  6. 6
    D. Nyholm, M. Ehrnebo, T. Lewander, C. G. Trolin, T. Bäckström, G. Panagiotidis, J. Spira, C. Nyström, S.-M. Aquilonius, Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers, Acta Neurologica Scandinavica, 2013, 127, 2
  7. 7
    Nicolaas I. Bohnen, Klaus Jahn, Imaging: What can it tell us about parkinsonian gait?, Movement Disorders, 2013, 28, 11
  8. 8
    Emily J Henderson, Stephen R Lord, Jacqueline CT Close, Andrew D Lawrence, Alan Whone, Yoav Ben-Shlomo, The ReSPonD trial - rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen, BMC Neurology, 2013, 13, 1, 188

    CrossRef

  9. 9
    Valerie E. Kelly, Alexis J. Eusterbrock, Anne Shumway-Cook, A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  10. 10
    Ing-Jy Tseng, Chii Jeng, Rey-Yue Yuan, Comparisons of forward and backward gait between poorer and better attention capabilities in early Parkinson's disease, Gait & Posture, 2012, 36, 3, 367

    CrossRef

  11. 11
    Sarah Vercruysse, Hannes Devos, Liesbeth Munks, Joke Spildooren, Jochen Vandenbossche, Wim Vandenberghe, Alice Nieuwboer, Elke Heremans, Explaining freezing of gait in Parkinson's disease: Motor and cognitive determinants, Movement Disorders, 2012, 27, 13
  12. 12
    Francisco J. Zagmutt, Marcy L. Tarrants, Indirect Comparisons of Adverse Events and Dropout Rates in Early Parkinson's Disease Trials of Pramipexole, Ropinirole, and Rasagiline, International Journal of Neuroscience, 2012, 122, 7, 345

    CrossRef

  13. 13
    D. Nyholm, K. Klangemo, A. Johansson, Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson’s disease, European Journal of Neurology, 2012, 19, 8
  14. 14
    Nico J. Weerkamp, Sytse U. Zuidema, Gerrit Tissingh, Petra J. E. Poels, Marten Munneke, Raymond T. C. M. Koopmans, Bastiaan R. Bloem, Motor Profile and Drug Treatment of Nursing Home Residents with Parkinson's Disease, Journal of the American Geriatrics Society, 2012, 60, 12
  15. 15
    Crispin Jenkinson, Sarah Dummett, Laura Kelly, Michele Peters, Jill Dawson, David Morley, Ray Fitzpatrick, The development and validation of a quality of life measure for the carers of people with Parkinson’s disease (the PDQ-Carer), Parkinsonism & Related Disorders, 2012, 18, 5, 483

    CrossRef

  16. 16
    Horst Baas, Wo stehen wir nach 100 Jahren mit L-Dopa?, DNP - Der Neurologe und Psychiater, 2012, 13, 3, 61

    CrossRef

  17. 17
    Meg E Morris, Hylton B Menz, Jennifer L McGinley, Frances E Huxham, Anna T Murphy, Robert Iansek, Mary Danoudis, Sze-Ee Soh, David Kelly, Jennifer J Watts, Falls and mobility in Parkinson's disease: protocol for a randomised controlled clinical trial, BMC Neurology, 2011, 11, 1, 93

    CrossRef

  18. 18
    Pedro J. Garcia-Ruiz, Gait disturbances in Parkinson disease. Did freezing of gait exist before levodopa? Historical review, Journal of the Neurological Sciences, 2011, 307, 1-2, 15

    CrossRef

  19. 19
    Ainhi D. Ha, Joseph Jankovic, Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia, 2011,

    CrossRef